These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14595431)

  • 1. Gradual adaptation of HIV to human host populations: good or bad news?
    Brander C; Walker BD
    Nat Med; 2003 Nov; 9(11):1359-62. PubMed ID: 14595431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and SIV CTL escape: implications for vaccine design.
    Goulder PJ; Watkins DI
    Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
    Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ
    J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
    Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
    Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of sequence evolution at epitopes for host antibodies and cytotoxic T-lymphocytes in human immunodeficiency virus type 1.
    Piontkivska H; Hughes AL
    Virus Res; 2006 Mar; 116(1-2):98-105. PubMed ID: 16214253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
    J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
    Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
    J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries.
    Blondelle SE; Moya-Castro R; Osawa K; Schroder K; Wilson DB
    Biopolymers; 2008; 90(5):683-94. PubMed ID: 18481808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-parasite coevolution and patterns of adaptation across time and space.
    Gandon S; Buckling A; Decaestecker E; Day T
    J Evol Biol; 2008 Nov; 21(6):1861-6. PubMed ID: 18717749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
    Mason RD; De Rose R; Kent SJ
    Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV CTL escape: at what cost?
    Smith SM
    Retrovirology; 2004 May; 1():8. PubMed ID: 15169568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary epidemiology and the dynamics of adaptation.
    Gandon S; Day T
    Evolution; 2009 Apr; 63(4):826-38. PubMed ID: 19154387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241-249 epitope.
    Tsukamoto T; Dohki S; Ueno T; Kawada M; Takeda A; Yasunami M; Naruse T; Kimura A; Takiguchi M; Matano T
    AIDS; 2008 May; 22(8):993-4. PubMed ID: 18453861
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.